Ticker Times

Company and market updates without any fluff

Earnings Digest - 2025-05-01

Published on: Thu May 01 2025

Tickers: AAPL ABNB AEE AIG AJG AME AMGN AMZN APD BDX BIIB BIO BLDR BR CAH CARR CHD CPT CVS D DTE DXCM ED EL EOG ES EXC FND FTV GWW HII HOLX HSY HUBB HWM ICE IDXX IR IRM JNPR K KIM LIN LLY LUMN LYV MA MCD MHK MPWR MRNA MSI MTD OGN PH PNW PWR SIRI SO SYK TEAM TFX TRGP
#earnings

$AAPL - Q2 2025 Earnings

  • Apple announced Q2 2025 earnings on May 1, 2025, with revenue of $95.4 billion (up 5% year-over-year) and earnings per share of $1.65 (up 8%), beating analyst expectations.
  • iPhone sales rose 2% to $46.84 billion, Mac sales grew 7% to $7.95 billion, iPad sales jumped 15% to $6.4 billion, and Services revenue hit a record $26.6 billion (up 12%).
  • The board raised the dividend by 4% to $0.26 per share and approved an additional $100 billion stock buyback.
  • CEO Tim Cook said tariffs could raise costs by $900 million next quarter and that all U.S. iPhone assembly will move to India by the end of 2026.
  • A US judge ruled Apple violated a court order on App Store practices; Apple also announced a 60% cut in global emissions since 2015.

$ABNB - Q1 2025 Earnings

  • Airbnb reported Q1 2025 financial results on May 1, 2025, with adjusted EPS of $0.24 (beating the $0.23 forecast) and revenue of $2.3 billion (up 6% year-over-year).
  • Adjusted EBITDA was $417 million (18% margin), and free cash flow for the quarter was $1.8 billion.
  • Airbnb repurchased $807 million in stock during Q1 2025 and launched an AI customer service agent, used by 50% of U.S. users.
  • 43 million nights and experiences were booked in Q1, up 8% from last year.
  • Airbnb expects Q2 revenue between $2.99 billion and $3.05 billion (9-11% growth) and plans a major product launch on May 13.

$AEE - Q1 2025 Earnings

  • Ameren reported Q1 2025 earnings on May 1, 2025: net income was $289 million ($1.07 per diluted share) versus $261 million ($0.98 per share) in Q1 2024.
  • Revenue rose to $2.1 billion, beating analyst forecasts of $1.92 billion; however, EPS of $1.07 missed the $1.08 estimate.
  • The company reaffirmed its full-year 2025 earnings guidance of $4.85 to $5.05 per diluted share and expects annual EPS growth of 6% to 8% through 2029.
  • Ameren Missouri reminded customers that LIHEAP energy assistance applications are due by May 31.
  • Ameren Illinois launched “Right Tree Right Place” grants and connected a mobile substation to address floodwaters near Old Shawneetown.

$AIG - Q1 2025 Earnings

  • AIG reported first-quarter 2025 results on May 1, 2025, with adjusted earnings per share of $1.17, beating analyst estimates of $0.99.
  • Net income was $698 million ($1.16 per diluted share), down from $1.19 billion ($1.74 per diluted share) in the same quarter last year.
  • Net premiums written totaled $4.5 billion, flat year-over-year as reported, but up 8% on a comparable basis; Global Commercial net premiums written rose 8% year-over-year.
  • The General Insurance combined ratio worsened to 95.8% from 89.8% last year, mainly due to $525 million in catastrophe losses, including $460 million from January California wildfires.
  • AIG returned $2.5 billion to shareholders and increased its quarterly dividend by 12.5% to $0.45 per share.

$AJG - Q1 2025 Earnings

  • On May 1, Arthur J. Gallagher & Co. (AJG) reported first quarter 2025 results: 14% revenue growth in core brokerage and risk management, 9% organic growth, net earnings margin up to 23%, and adjusted EBITDAC up 26% year-over-year.
  • AJG completed 11 new mergers in Q1, adding about $100 million in estimated annualized revenue.
  • The company acquired Woodruff Sawyer (San Francisco) on April 10, and First Capital Financial Services (New Zealand) on April 30; terms were not disclosed.
  • On April 3, AJG announced acquisitions of Encore Insurance Services (Canada), Tresidder Insurance Brokers (Australia), and Bircroft Insurance Services (UK); terms were not disclosed.
  • Compensation expense ratio improved, helped by higher interest income and headcount controls.

$AME - Q1 2025 Earnings

  • AMETEK’s Board of Directors declared a regular quarterly dividend of $0.28 per share for Q2 2024, payable on June 28, 2024, to shareholders of record as of June 14, 2024.
  • Patrick L. Williams was appointed as Vice President and General Manager of the MRO Division on May 9, 2024.
  • AMETEK’s MAE brand will exhibit cleaning innovations at Interclean in Amsterdam from May 14-17, 2024.
  • Dunkermotoren and MAE will showcase new intelligent motors and IIoT solutions at SPS Italia in Parma from May 28-30, 2024.

$AMGN - Q1 2025 Earnings

  • On May 1, 2025, Amgen reported Q1 2025 earnings per share of $4.90, beating forecasts by 14.2%.
  • Revenue for Q1 2025 was $8.15 billion, up 9% year-over-year and above expectations.
  • Growth was driven by strong sales of key brands and biosimilars, with biosimilars revenue up 35% to over $700 million.
  • Despite strong results, Amgen’s stock fell 2.49% after the earnings report.
  • Amgen reaffirmed its 2025 revenue and earnings guidance, and reported a 4% increase in operating expenses and 12% growth in R&D spending.

$AMZN - Q1 2025 Earnings

  • Amazon announced its 10th annual Prime Day will be held on July 16-17, 2024.
  • Prime Day offers exclusive deals for Prime members across more than 35 product categories.
  • New deals will drop often, including some invite-only offers for high-demand products.
  • Last year, customers saved nearly $24 billion from Amazon deals, with over $2.5 billion saved during Prime Day 2023.

$APD - Q2 2025 Earnings

  • On May 1, 2025, Air Products reported a second quarter GAAP loss per share of $7.77 and a net loss of $1.7 billion, impacted by a $2.3 billion after-tax charge from exiting three U.S. projects.
  • Adjusted earnings per share were $2.69, and adjusted EBITDA was $1.2 billion for the quarter.
  • The company increased its quarterly dividend to $1.79 per share, marking its 43rd consecutive annual increase.
  • Eduardo F. Menezes was named CEO (effective February 7, 2025); Wayne T. Smith and Dennis H. Reilley were named Chairman and Vice Chairman.
  • Air Products revised its 2025 adjusted EPS guidance to $11.85–$12.15 and expects about $5 billion in capital expenditures for the year.
  • The company signed a solar Power Purchase Agreement in Taiwan and secured long-term supply deals for industrial gases with a major semiconductor manufacturer there.

$BDX - Q2 2025 Earnings

  • Becton, Dickinson and Company (BDX) reported Q2 FY2025 results on May 1, 2025: revenue was $5.27 billion, up 4.5% year-over-year but below the $5.35 billion estimate.
  • Adjusted EPS was $3.35, beating the $3.28 estimate and up 5.7% from last year; net income fell 42.7% to $308 million.
  • BD Medical segment revenue grew 12.7%; U.S. revenue rose 7.0%, international revenue increased 1.2%.
  • Adjusted operating profit dropped 16% to $682 million; operating margin shrank to 12.9%.
  • Company updated FY2025 guidance: revenue of $21.8–$21.9 billion and adjusted EPS of $14.06–$14.34; plans $2.5 billion investment in U.S. manufacturing over five years.
  • Launched the Phasix™ ST Umbilical Hernia Patch and started a clinical trial for GalaFLEX LITE™ Scaffold; declared a quarterly dividend of $1.04 per share, payable June 30, 2025.

$BIIB - Q1 2025 Earnings

  • Biogen reported Q1 2025 earnings on May 1, 2025; EPS was $3.32, compared to $3.67 last year.
  • Next earnings report is expected on August 7, 2025, with analysts forecasting EPS of $4.10, an 11.17% decrease year-over-year.
  • Full-year 2025 consensus EPS forecast is $15.46, with estimates ranging from $14.18 to $16.26.

$BIO - Q1 2025 Earnings

  • Bio-Rad announced Q1 2025 financial results on May 1, 2025.
  • Earnings per share (EPS) were $2.54, beating the forecasted $1.80.
  • Revenue was $585.4 million, slightly above expectations but down 4.2% from last year due to lower life sciences demand in the Americas.
  • Non-GAAP operating margin rose to 10.8% from 9.7% in Q1 2024.
  • Free cash flow increased to $96 million from $30 million a year ago.
  • Bio-Rad expects 2025 non-GAAP revenue to range from a 1% decrease to 1.5% growth.
  • New clinical trial data showed Bio-Rad’s ddPCR technology links tumor DNA changes to lung cancer treatment outcomes.

$BLDR - Q1 2025 Earnings

  • Builders FirstSource reported first quarter 2025 results on April 3, 2025, with adjusted EPS of $1.51 (above the expected $1.42) and revenue of $3.7 billion (slightly above the $3.67 billion forecast).
  • Net sales fell 6% year-over-year, gross profit dropped 14% to $1.1 billion, and adjusted EBITDA declined 32% to $369 million.
  • Gross margin was 30.5%, down 290 basis points; free cash flow was $45 million.
  • The company announced a new $500 million share repurchase authorization and bought back 3.3 million shares for $391 million in April.
  • 2025 guidance: net sales of $16.05–$17.05 billion, adjusted EBITDA of $1.7–$2.1 billion, and free cash flow of $800 million–$1.2 billion.

$BR - Q3 2025 Earnings

  • Broadridge Financial Solutions reported Q3 2025 results on May 1, 2025, with adjusted EPS of $2.44, beating estimates and up 9% year-over-year.
  • Revenue was $1.81 billion, up 5% from last year but below analyst expectations of $1.86 billion.
  • Recurring revenue grew 8% to $1.2 billion; Global Technology and Operations segment rose 9% to $464 million; Investor Communication Solutions segment increased 4% to $1.35 billion.
  • Adjusted operating income margin improved to 22.4%, and revenue retention rate remained high at 98%.
  • The company reaffirmed its 2025 outlook for 6–8% recurring revenue growth and 8–12% adjusted EPS growth.

$CAH - Q3 2025 Earnings

  • On May 1, 2025, Cardinal Health reported Q3 adjusted EPS of $2.35, beating estimates by 9.3% and up 12.4% year-over-year.
  • GAAP EPS was $2.10, up from $1.07 last year.
  • Total reported revenue was nearly $55 billion; adjusting for a customer contract expiration, revenue rose 19% year-over-year.
  • Pharmaceutical segment revenue was flat at $50.4 billion, but up 20% excluding the expired contract; Medical segment revenue rose 2% to $3.2 billion.
  • The company raised its full-year EPS guidance to $8.05–$8.15 and ended the quarter with $3.3 billion in cash.

$CARR - Q1 2025 Earnings

  • Carrier Global reported Q1 2025 earnings on May 1, 2025, with adjusted EPS of $0.65, beating estimates and up 27.5% year-over-year.
  • Quarterly net sales were $5.22 billion, down 4% from last year but above expectations.
  • Carrier restructured its business into four new climate-focused segments on May 1, 2025.
  • The company raised its 2025 adjusted EPS outlook to $3.00–$3.10 and updated its sales outlook to about $23 billion.
  • The Americas segment grew revenues by 9% year-over-year, while Europe, Asia Pacific Middle East & Africa, and Transportation segments saw revenue declines.

$CHD - Q1 2025 Earnings

  • Church & Dwight reported Q1 2025 results on May 1, 2025: net sales fell 2.4% to $1.47 billion, missing its growth outlook.
  • Organic sales dropped 1.2%, mainly due to a 1.4% decrease in volume.
  • Adjusted EPS was $0.91 (down 5.2%), but slightly beat the company’s $0.90 outlook.
  • Domestic Division organic sales dropped 3%, with inventory reductions and slower consumption; 4 out of 7 power brands gained share.
  • International Division saw 5.8% organic growth, led by HERO, THERABREATH, and WATERPIK brands.
  • Gross margin decreased to 45.0%, mainly from higher costs and lower volumes; marketing expenses also declined.

$CPT - Q1 2025 Earnings

  • Camden Property Trust announced Q1 2025 results on May 1, 2025, reporting property revenue of $390.6 million, up from $383.1 million in Q1 2024.
  • Net income per diluted share was $0.36, down from $0.77 last year; Core FFO per diluted share was $1.72, up from $1.70.
  • Same property revenues rose 0.8% and Net Operating Income (NOI) increased 0.9% compared to Q1 2024.
  • Full-year 2025 Core FFO guidance was raised to a midpoint of $6.78 per share, up from $6.75, due to expected lower borrowing costs.

$CVS - Q1 2025 Earnings

  • On May 1, 2025, CVS Health reported first quarter 2025 earnings with $94.6 billion in revenue, up 7% year-over-year and above expectations.
  • GAAP diluted EPS rose to $1.41 (from $0.88), and adjusted EPS increased to $2.25 (from $1.31). Net income grew 58.5% to $1.78 billion.
  • CVS raised its 2025 adjusted EPS guidance to $6.00–$6.20 and cash flow guidance to about $7.0 billion, but lowered GAAP EPS guidance to $4.23–$4.43.
  • The company plans to exit the individual exchange business by 2026, expecting $350–$400 million in losses for 2025 in that segment.
  • CVS will partner with Novo Nordisk to offer Wegovy at lower cost with a July 1, 2025 formulary update, and announced new leadership appointments in April and May 2025.

$D - Q1 2025 Earnings

  • Dominion Energy announced first-quarter 2025 earnings on May 1, reporting GAAP net income of $646 million ($0.75 per share), up from $441 million ($0.50 per share) last year.
  • Operating earnings (non-GAAP) for Q1 2025 were $803 million ($0.93 per share), up from $485 million ($0.55 per share) in Q1 2024.
  • The company reaffirmed its full-year 2025 operating earnings guidance of $3.28 to $3.52 per share and maintained previous financial guidance.
  • Dominion Energy Virginia proposed new base and fuel rate increases for residential customers, with base rates rising by $8.51/month in 2026 and $2.00/month in 2027, and a fuel rate increase of $10.92/month starting July 1, 2025.
  • The Coastal Virginia Offshore Wind project is about 50% complete and on track for completion by the end of 2026; Dominion also proposed a new rate class for high energy users like data centers.

$DTE - Q1 2025 Earnings

  • DTE Energy reported first-quarter 2025 earnings on May 1, 2025, with net income of $445 million ($2.14 per share), up from $313 million ($1.51 per share) last year.
  • Operating earnings were $436 million ($2.10 per share), beating estimates by 6.1%.
  • The company invested over $850 million in its utilities in Q1 and plans to invest $4.4 billion in 2025; the five-year capital plan increased to $30 billion.
  • DTE requested a $574 million electricity rate increase in Michigan, which could raise residential bills by 11.1% if approved.
  • Customer outage times improved by nearly 60% year-to-date compared to Q1 2024.

$DXCM - Q1 2025 Earnings

  • DexCom reported Q1 2025 financial results on May 1, 2025, with revenue of $1.04 billion, beating the forecasted $1.02 billion.
  • U.S. revenue rose 15% to $751 million; total revenue grew 14% year-over-year.
  • Earnings per share were $0.32, slightly below the expected $0.33; net income was $127.7 million.
  • The company announced a $750 million share repurchase program.
  • DexCom received FDA clearance for its G7 15 Day Continuous Glucose Monitoring System, set to launch in the second half of the year.
  • DexCom is addressing a March FDA warning letter related to facility inspections.

$ED - Q1 2025 Earnings

  • Con Edison announced a quarterly dividend of 85 cents per share on April 17, 2025.
  • The New York State Public Service Commission held hearings on April 8 and 9, 2025, about Con Edison’s proposed electric and gas delivery rate increases.
  • Con Edison is seeking to raise annual electric delivery revenues by $1.6 billion (an 11.4% increase) and gas delivery revenues by $440 million (a 19.1% increase).
  • The proposed increases are to support clean energy investments, infrastructure upgrades, system reliability, safety, and energy efficiency programs.

$EL - Q3 2025 Earnings

  • On May 1, 2025, Estée Lauder reported Q3 adjusted earnings per share of $0.65, beating expectations of $0.29.
  • Q3 revenue fell 9.9% year-over-year to $2.66 billion, missing the estimate of $3.51 billion; net sales dropped 10%.
  • By segment, Q3 sales fell: skin care by 11%, hair care by 10%, makeup by 7%, and fragrance by 1%.
  • The company is restructuring, planning to cut up to 7,000 jobs; over 2,600 positions have been eliminated so far.
  • Estée Lauder expects a wider net sales decline in global travel retail in Q4 and forecasts an 8-9% overall sales drop for 2025.
  • Michael Bowes was named Chief People Officer (effective April 1, 2025); Brian Franz was named Chief Technology, Data & Analytics Officer (effective April 21, 2025); Carl Haney will leave the company.

$EOG - Q1 2025 Earnings

  • EOG Resources reported Q1 2025 results on May 1, 2025, with adjusted net income of $1.6 billion ($2.82 per share), slightly missing estimates.
  • Total revenue for Q1 2025 was $5.67 billion, below forecasts, and crude oil/condensate volumes rose to 502.1 MBbld from 487.4 MBbld last year.
  • Free cash flow was $1.3 billion; $1.3 billion was returned to shareholders via dividends ($0.975/share declared, payable July 31) and buybacks.
  • EOG announced a new offshore oil discovery in Trinidad, called the Beryl oil discovery.
  • The company projects 3% oil volume and 6% total production growth in 2024, with continued focus on efficiency and $6.2 billion capital spending.

$ES - Q1 2025 Earnings

  • Microsoft, Meta Platforms, Amazon, and Apple announced earnings in the past week, with Microsoft and Meta showing strong results that boosted optimism in AI stocks.
  • On May 1st, the S&P 500 rose 0.63% and the Nasdaq jumped 1.52%.
  • Amazon reported net income of $17.1 billion, beating expectations, but gave a weaker outlook for operating income, causing shares to fall after hours.
  • Apple narrowly beat earnings expectations but warned of an extra $900 million in tariff costs this quarter, leading to a drop in share price.
  • Jobless claims were higher than expected on May 1st, and the 10-year Treasury yield climbed to 4.22%.

$EXC - Q1 2025 Earnings

  • Exelon reported fiscal Q1 2025 earnings on May 1, 2025, with GAAP net income of $0.90 per share and adjusted operating earnings of $0.92 per share, up from $0.66 per share last year.
  • Net income rose 38% year-over-year; revenue increased to $6.71 billion from $6.04 billion in Q1 2024.
  • Exelon reaffirmed its full-year 2025 adjusted operating earnings guidance of $2.64 to $2.74 per share and expects 5–7% annual operating EPS growth from 2024 to 2028.
  • The Board declared a regular quarterly dividend of $0.40 per share, payable June 13, 2025, to shareholders of record as of May 12, 2025.
  • New leadership appointments became effective May 1, 2025, with Carim Khouzami named Executive Vice President, Transmission and Development, and Tamla Olivier as President and CEO of BGE; W. Paul Bowers became Independent Board Chair on April 29, 2025.

$FND - Q1 2025 Earnings

  • Floor & Decor announced Q1 fiscal 2025 results on May 1, 2025.
  • Net sales rose 5.8% to $1.161 billion; gross profit increased 8.1% to $508.6 million.
  • Diluted EPS was $0.45, slightly down from $0.46 last year, but met analyst expectations.
  • Comparable store sales fell 1.8%; net income decreased 2.3% to $48.9 million.
  • Four new warehouse stores opened; company plans to open 25 more in 2025 and expand its semi-custom cabinet offerings.

$FTV - Q1 2025 Earnings

  • Fortive reported Q1 2025 earnings on May 1, 2025, with net earnings of $172 million and adjusted net earnings of $292 million.
  • Adjusted earnings per share were $0.85, meeting expectations; revenue fell 3% year-over-year to $1.47 billion.
  • Adjusted operating profit margin rose to 25.3%, up 20 basis points, mainly due to strong Intelligent Operating Solutions performance.
  • The company updated its 2025 adjusted EPS guidance due to lower demand in Precision Technologies and expected tariff impacts.
  • Fortive plans to separate its Precision Technologies business by the end of Q2 2025 and will give new guidance for New Fortive and Reliant after the split.

$GWW - Q1 2025 Earnings

  • On May 1, 2025, W.W. Grainger reported first-quarter diluted earnings per share of $9.86, up 2.5% from last year and above analyst expectations.
  • Quarterly revenue was $4.3 billion, a 1.7% year-over-year increase, but slightly below forecasts.
  • Operating margin was 15.6%; operating cash flow reached $646 million, with $380 million returned to shareholders through dividends and share repurchases.
  • The company reaffirmed its full-year 2025 guidance.
  • On April 30, 2025, Grainger’s board raised the quarterly dividend by 10% to $2.26 per share, marking 54 consecutive years of increases.

$HII - Q1 2025 Earnings

  • HII reported Q1 2025 results on May 1: revenue was $2.7 billion (down 2.5% year-over-year) and net earnings were $149 million, with EPS of $3.79 (beating estimates).
  • Operating margin was 5.9%. Segment operating margin increased to 6.3% (from 6.1% last year), driven by Mission Technologies and Newport News Shipbuilding.
  • New contract awards in Q1 totaled $2.1 billion, raising backlog to $48 billion ($28 billion funded) as of March 31, 2025.
  • HII reaffirmed 2025 financial guidance and projects revenue to grow to $15 billion by 2030, with over $50 billion in expected awards for 2025 and 2026.
  • On April 30, 2025, HII and General Dynamics Electric Boat were awarded a contract modification to build two more Block V Virginia-class submarines for FY 2024; HII also declared a quarterly dividend and launched a new advertising campaign.

$HOLX - Q2 2025 Earnings

  • Hologic reported Q2 fiscal 2025 results on May 1, 2025, with revenue of $1,005.3 million, slightly above guidance but down 1.2% year-over-year.
  • GAAP diluted EPS was ($0.08), down from $0.72 last year due to $220.9 million in impairment charges; non-GAAP diluted EPS was $1.03, matching last year and the high end of guidance.
  • Diagnostics revenue rose 0.8% to $453.6 million, with organic diagnostics (excluding COVID-19) up 4.5%; COVID-19 revenue dropped 30.3%.
  • Surgical revenue grew 4.2% to $162.5 million, mainly from the Gynesonics acquisition and strong international sales.
  • The company kept its annual revenue guidance but lowered EPS forecasts, citing fewer selling days, weaker revenue from China, and extended gantry replacement cycles.

$HSY - Q1 2025 Earnings

  • On May 1, 2025, Hershey reported Q1 2025 net sales of $2.81 billion, down 13.8% year-over-year, and net income of $224.2 million, down 71.7%.
  • Adjusted earnings per share were $2.09, down 31.9% but above analyst expectations of $1.95.
  • North America Confectionery sales fell 15%, mainly due to lower volume from prior inventory build, Easter timing, and fewer shipping days; Salty Snacks sales rose 1%.
  • Gross margin dropped to 33.7% from 51.5% last year due to higher costs and lower sales; operating profit fell 65.1% to $369.2 million.
  • Hershey launched Reese’s Filled Pretzels nationwide and announced a “HERSHEY” movie about founder Milton Hershey, filming starting May 2025.

$HUBB - Q1 2025 Earnings

  • Hubbell announced Q1 2025 financial results on May 1, 2025, showing Electrical Solutions segment net sales rose to $508 million from $505 million last year, with organic net sales up 5%.
  • Free cash flow for Q1 2025 was $11 million, down from $52 million in Q1 2024.
  • The company expects full-year 2025 total sales and organic net sales growth of 6-8%, and adjusted diluted EPS of $17.35-$17.85 (excluding about $1.40/share in acquisition-related amortization).
  • Hubbell approved a new $500 million share repurchase program in February 2025 (effective until February 2028), in addition to $260 million remaining on its prior buyback program.
  • A quarterly dividend of $1.32 per share was declared on April 25, 2025, payable June 16, 2025, to shareholders of record on May 30, 2025.

$HWM - Q1 2025 Earnings

  • Howmet Aerospace announced Q1 2025 results on May 1, 2025, with revenue of $1.94 billion, up 6% year-over-year, and net income of $344 million ($0.84 per share), beating analyst estimates.
  • Commercial aerospace sector revenue grew 9%; operating income margin rose to 25.4%, up 520 basis points from last year.
  • Free cash flow was $134 million, up from $95 million last year; the company repurchased $125 million in stock in Q1 and another $100 million in April.
  • Quarterly dividend doubled to $0.10 per share.
  • Fitch Ratings upgraded Howmet’s Long-Term Issuer Default Rating to ‘BBB+’ due to improved financials.
  • Company invoked force majeure over potential Trump-era tariff impacts, possibly suspending some shipments.

$ICE - Q1 2025 Earnings

  • Intercontinental Exchange (ICE) reported strong Q1 2025 results on May 1, 2025.
  • ICE approved a second quarter dividend of $0.48 per share on May 1, 2025.
  • ICE was among the noteworthy ETFs experiencing inflows on April 25, 2025.

$IDXX - Q1 2025 Earnings

  • IDEXX Laboratories announced first quarter 2025 financial results on May 1, 2025.
  • Revenue was $998 million, up 4% as reported and 5% organically.
  • Earnings per share were $2.96, increasing 5% as reported and 7% on a comparable basis.
  • The company raised its 2025 revenue outlook to $4,095 million–$4,210 million, $40 million higher at the midpoint.
  • IDEXX launched the IDEXX Cancer Dx™, a new test for early detection of canine lymphoma in North America.

$IR - Q1 2025 Earnings

  • Ingersoll Rand reported first quarter 2025 results on May 1, 2025, with a profit of $186.5 million ($0.46 per share), down from $202.2 million ($0.50 per share) last year.
  • Adjusted earnings were $291.3 million ($0.72 per share), missing analyst expectations of $0.74 per share.
  • Revenue rose 2.8% year-over-year to $1.716 billion.
  • The company declared a quarterly cash dividend of $0.02 per share.
  • For 2025, Ingersoll Rand expects adjusted earnings per share of $3.38 to $3.50 and revenue growth of 3% to 5%.

$IRM - Q1 2025 Earnings

  • Iron Mountain reported first-quarter 2025 results on May 1, 2025, with record revenue of $1.6 billion, up 7.8% year-over-year.
  • Earnings per share (EPS) were $0.43, beating analyst expectations by $0.02; revenue also surpassed estimates.
  • Growth businesses (data center, digital, ALM) grew over 20%; storage rental revenue rose 7% to $948 million, and service revenue increased 9% to $644 million.
  • Adjusted EBITDA reached a record $580 million for the quarter.
  • The company raised its 2025 guidance, now expecting revenue between $6.74 and $6.89 billion and adjusted EBITDA between $2.505 and $2.555 billion.
  • A quarterly cash dividend of $0.785 per share was declared, payable July 3, 2025, to shareholders of record on June 16, 2025.

$JNPR - Q1 2025 Earnings

  • Juniper Networks reported Q1 2025 earnings on May 1, 2025, with net revenue of $1.28 billion, up 11% year-over-year and matching estimates.
  • GAAP operating margin improved to 7.0% from (1.2)% last year; non-GAAP operating margin rose to 14.3% from 10.6%.
  • GAAP net income was $64.1 million, with diluted EPS of $0.19; non-GAAP EPS was $0.43, beating estimates by $0.02.
  • Total cash and investments reached $1.97 billion as of March 31, 2025, up from $1.53 billion a year earlier; Q1 operating cash flow was $316.5 million.
  • Juniper’s $40.00/share proposed acquisition by Hewlett Packard Enterprise faces a DOJ lawsuit; trial begins July 9, 2025, and share buybacks are suspended during the process.

$K - Q1 2025 Earnings

  • Kellanova reported its first quarter 2025 financial results on May 1, 2025.
  • Kellanova declared a regular dividend of $0.57 per share on April 25, 2025, payable June 13, 2025, to shareholders of record on May 30, 2025.
  • WK Kellogg Co announced a quarterly dividend of $0.165 per share on May 1, 2025, payable June 13, 2025, to shareholders of record on May 30, 2025.
  • WK Kellogg Co will release its first quarter 2025 financial results on May 6, 2025.

$KIM - Q1 2025 Earnings

  • Kimco Realty reported Q1 2025 results on May 1, 2025, with net income per diluted share of $0.18, up from a loss of ($0.03) last year.
  • Funds From Operations (FFO) per diluted share grew 12.8% to $0.44, and Same Property Net Operating Income (NOI) increased by 3.9%.
  • Over four million square feet were leased in the quarter, with new lease spreads near 49%. 85% of annual base rent now comes from grocery-anchored properties.
  • Kimco acquired The Markets at Town Center in Jacksonville for $108 million and other properties, while selling some assets for $41.3 million.
  • The company repaid $500 million in unsecured debt and $48.9 million in mortgage debt, with Moody’s affirming a Baa1 rating and raising its outlook to positive.

$LIN - Q1 2025 Earnings

  • Linde reported first-quarter 2025 results on May 1: net income was $1,673 million and diluted EPS was $3.51, both up 3-5% from last year.
  • Adjusted net income was $1,880 million and adjusted EPS was $3.95, both up 3-5% year-over-year.
  • Total sales were $8,112 million, flat year-over-year; underlying sales rose 1% from higher prices, despite lower volumes.
  • Operating cash flow increased 11% to $2,161 million; $1,808 million was returned to shareholders via dividends and buybacks.
  • Linde expects second-quarter adjusted EPS of $3.95–$4.05, up 3-5% from last year, and announced a new dividend and a supply expansion deal with Samsung in South Korea.

$LLY - Q1 2025 Earnings

  • Eli Lilly reported Q1 2025 financial results on May 1, 2025, with revenue up 45% to $12.73 billion, mainly from Mounjaro and Zepbound sales.
  • Eli Lilly announced positive Phase 3 results for its oral GLP-1 drug orforglipron in type 2 diabetes, showing significant reductions in A1C and weight.
  • The company plans to seek regulatory approval for orforglipron for weight management by the end of 2025 and for type 2 diabetes in 2026.
  • Eli Lilly presented new cancer research data at the 2025 AACR Annual Meeting, including agents targeting SMARCA2 and KRAS mutations.
  • The LillyDirect platform was expanded to help patients connect with Alzheimer’s specialists.

$LUMN - Q1 2025 Earnings

  • Lumen Technologies reported Q1 2025 results on May 1, 2025, with a net loss of $201 million, compared to a net income of $57 million in Q1 2024.
  • Diluted loss per share was $0.20 in Q1 2025, down from $0.06 earnings per share last year.
  • Q1 2025 revenue was $3.182 billion, a decrease from $3.290 billion in Q1 2024; adjusted EBITDA fell to $929 million from $977 million.
  • Lumen partnered with Google to provide direct fiber access to Google Cloud and deployed more Network-as-a-Service (NaaS) ports and services.
  • The company launched Lumen Defender Plus, a new threat intelligence service, and partnered with Churchill Downs Racetrack to enhance network capacity for the Kentucky Derby.

$LYV - Q1 2025 Earnings

  • Live Nation reported Q1 2025 results on May 1, showing a loss of $0.32 per share, $0.10 worse than expected, and revenue of $3.38 billion, which missed estimates and was down 11% from last year.
  • Ticket sales are up, with 95 million sold (double-digit growth) and stadium ticket sales rising over 80%.
  • Ticketmaster’s ticketing volume for 2025 events is up 5%, and Gross Transaction Value (GTV) is up 10%; for early April, concert ticket sales rose 25% and GTV jumped 45%.
  • Deferred revenue hit records: $5.4 billion for Concerts (up 24%) and $270 million for Ticketmaster (up 13%).
  • New tours announced this week include José María Napoleón’s Tour De Despedida USA 2025, Wiz Khalifa and Sean Paul’s ‘Good Vibes Only Tour’, and multiple artists for Ohana Festival 2025.

$MA - Q1 2025 Earnings

  • On May 1, 2025, Mastercard reported Q1 2025 earnings with revenue of $7.25 billion (up 14.2% year-over-year), beating estimates by 1.81%.
  • Earnings per share (EPS) were $3.73, up from $3.31 last year and above the estimate of $3.57.
  • Switched transactions reached 40.1 billion, slightly below estimates, while purchase volume was $1,993 billion, also below analyst expectations.
  • On April 29, 2025, Mastercard launched “Agent Pay,” a new AI-driven payment technology, with partnerships including Microsoft, IBM, Braintree, and Checkout.com.
  • Also on April 29, Mastercard invested $300 million for a 3% stake in Corpay’s cross-border business and named Corpay an exclusive partner for currency risk management and large-ticket payments.
  • On April 28, 2025, Mastercard introduced new services for stablecoin transactions, partnering with Circle, Paxos, and OKX.

$MCD - Q1 2025 Earnings

  • McDonald’s reported first quarter 2025 results on May 1, 2025.
  • Global comparable sales fell 1.0% in Q1 2025; U.S. comparable sales dropped 3.6%, the largest decline since 2020.
  • Consolidated revenues decreased 3% year-over-year to $5.96 billion.
  • Diluted EPS was $2.60, down 2%; adjusted EPS (excluding $66 million in restructuring charges) was $2.67.
  • The company is expanding its U.S. value menu and launching a $5 Meal Deal for the summer.

$MHK - Q1 2025 Earnings

  • Mohawk Industries reported Q1 2025 results on May 1, 2025, with net earnings of $73 million ($1.15 EPS), down from $105 million ($1.64 EPS) in Q1 2024.
  • Net sales fell 5.7% to $2.5 billion from $2.7 billion a year ago; adjusted for days and exchange rates, sales dropped 0.7%.
  • The company faces a new 145% tariff on Chinese LVT imports, expected to cost $50 million annually; plans include price hikes and supply chain changes.
  • Segment sales declined: Global Ceramic -4.9%, Flooring Rest of World -8.8%, Flooring North America -4.2% (or -1.1% on constant days); operating margin in Flooring North America was 1.1% reported, 3.0% adjusted.
  • Mohawk expects Q2 2025 adjusted EPS between $2.52 and $2.62 and $100 million in restructuring benefits for 2025; 225,000 shares were repurchased for $26 million in the quarter.

$MPWR - Q1 2025 Earnings

  • Monolithic Power Systems reported Q1 2025 results on May 1, 2025, with adjusted EPS of $4.04, beating analyst expectations of $4.00.
  • Revenue reached $637.6 million, above estimates and up 39.2% from $457.9 million in Q1 2024.
  • The storage and computing segment saw a 38% quarter-over-quarter revenue increase, contributing to record quarterly revenue.
  • Non-GAAP operating income grew to $221.5 million from $151.6 million a year ago; gross margin stayed stable at 55.7%.
  • For Q2, the company expects revenue between $640 million and $660 million, projects a 15% non-GAAP tax rate, and plans further expansion outside China.

$MRNA - Q1 2025 Earnings

  • Moderna reported Q1 2025 financial results on May 1, 2025, with revenue of $108 million, down from $167 million in Q1 2024.
  • Net loss was $1.0 billion ($2.52 per share), compared to a net loss of $1.2 billion ($3.07 per share) last year.
  • The company expects full-year 2025 revenue between $1.5 billion and $2.5 billion and plans to cut annual operating expenses by $1.5 billion by 2027.
  • Positive Phase 3 results were shared for the RSV vaccine (mRNA-1345) and flu/COVID combo vaccine (mRNA-1083), with regulatory approval timelines set for June 12, 2025 (mRNA-1345) and 2026 (mRNA-1083).
  • FDA set a PDUFA decision date of May 31, 2025, for Moderna’s next-generation COVID-19 vaccine (mRNA-1283).

$MSI - Q1 2025 Earnings

  • On April 21, 2025, Motorola Solutions launched SVX and Assist, a new device for public safety that combines a two-way radio, body camera, and AI.
  • Also on April 21, 2025, Motorola Solutions announced partnerships with BRINC and SkySafe to improve drone response and detection for public safety.
  • The company will report its first-quarter 2025 earnings on May 1, 2025, with a conference call at 5:00 PM ET.

$MTD - Q1 2025 Earnings

  • On May 1, 2025, Mettler-Toledo reported first quarter 2025 earnings, showing 15% revenue growth and a 20% increase in earnings per share.
  • The company lowered its annual profit forecast for 2025 to $41.25–$42.00 per share, down from $42.35–$43.00, due to market uncertainty and expected $115 million in annualized tariff costs.
  • Mettler-Toledo launched four new lines of laboratory balances with improved accuracy, touch controls, and better connectivity.
  • The company plans to expand its European manufacturing facilities to boost production capacity by 20% over the next two years.

$OGN - Q1 2025 Earnings

  • Organon reported Q1 2024 earnings on May 2, 2024, with revenue of $1.62 billion, up 5% year-over-year (7% at constant currency).
  • Diluted EPS was $0.78; non-GAAP adjusted EPS was $1.22, both including a $15 million expense for acquired R&D and milestones.
  • Net income was $201 million; adjusted EBITDA was $538 million; company reaffirmed full-year 2024 financial guidance.
  • The Board declared a $0.28 per share quarterly dividend, payable June 13, 2024, to shareholders of record on May 13, 2024.
  • Positive Phase 3 ADORING 3 study results for VTAMA® cream showed 84% of atopic dermatitis patients maintained low disease activity in an average 80-day treatment-free period.

$PH - Q3 2025 Earnings

  • Parker-Hannifin reported fiscal Q3 2025 earnings on May 1, 2025, with sales up 2% to $5.0 billion and adjusted EPS rising 7% to $6.94, beating estimates.
  • Net income jumped 32% to $961 million; adjusted segment operating margin hit a record 26.3%.
  • The Aerospace Systems segment saw 12% organic sales growth, a record backlog of $7.3 billion, and a 14% increase in orders.
  • The company repurchased $650 million in shares and raised its quarterly dividend by 10% to $1.80, marking its 300th consecutive dividend payment.
  • Fiscal 2025 guidance was updated to about -1% sales growth and adjusted EPS of $26.60–$26.80.

$PNW - Q1 2025 Earnings

  • On May 1, 2025, Pinnacle West Capital Corp. reported a net loss of $4.6 million ($0.04 per share) for Q1 2025, down from a net income of $16.9 million ($0.15 per share) in Q1 2024.
  • The company said the loss was expected and kept its full-year 2025 earnings guidance unchanged.
  • Losses were mainly due to higher operations and maintenance costs, more depreciation and interest expenses, and lower benefit credits.
  • Positive factors included new customer rates, investment gains, lower taxes, and higher transmission revenue.
  • Arizona Public Service, Pinnacle West’s main subsidiary, saw retail customer growth of 2.3% and sales growth of 2.1% in Q1, driven by Arizona’s growing population.

$PWR - Q1 2025 Earnings

  • Quanta Services (PWR) reported First Quarter 2025 results on May 1, 2025.
  • Non-GAAP EPS was $1.78, beating the consensus estimate of $1.72.
  • Quarterly revenue was $6.23 billion, up 23.9% year-over-year and above the $5.88 billion estimate.

$SIRI - Q1 2025 Earnings

  • SiriusXM reported Q1 2025 results on May 1, 2025, with revenue of $2.07 billion, down 4% year-over-year and below estimates.
  • Adjusted earnings per share were $0.59, missing the expected $0.67.
  • Net income was $24 million; adjusted EBITDA was $629 million, down 3% from last year.
  • The company lost 303,000 self-pay subscribers in Q1 2025.
  • SiriusXM maintained its full-year 2025 guidance and mentioned new vehicle partnerships with Tesla and Rivian to attract more subscribers.

$SO - Q1 2025 Earnings

  • On May 1, 2025, Southern Company reported Q1 2025 adjusted earnings per share of $1.23, beating expectations of $1.19.
  • Revenue for the quarter was $7.78 billion, above the forecast of $7.31 billion, and up 17% from last year.
  • Adjusted EPS rose 19.4% year-over-year, mainly driven by regulated utilities, which made up 76% of EPS.
  • The company announced an 8¢ increase to its annual dividend, now $2.96 per share, marking 24 years of consecutive increases.
  • Southern Company expects Q2 2025 adjusted EPS of $0.85 and maintains a long-term EPS growth target of 5-7%.

$SYK - Q1 2025 Earnings

  • Stryker reported first quarter 2025 results on May 1, 2025, with adjusted EPS of $2.84, up 13.6% from last year.
  • U.S. organic sales grew 10.7%, and international sales grew 8.5%, with strong performance in Australia, New Zealand, Japan, and Europe.
  • Stryker completed the acquisition of Inari Medical, Inc., and sold its U.S. spinal implants business to VB Spine, LLC.
  • The company expects full-year organic sales growth of 8.5% to 9.5% and adjusted EPS of $13.20 to $13.45.
  • Stryker’s annual shareholder meeting and vote will be held on May 8, 2025.

$TEAM - Q3 2025 Earnings

  • Atlassian reported Q3 FY2025 results on May 1, 2025, with revenue of $1.36 billion, up 14% year-over-year and above estimates.
  • Adjusted earnings per share were $0.97, beating analyst expectations.
  • Subscription revenue rose 19% to $1.27 billion; Cloud revenue grew 25% to $880.4 million; Data Center revenue increased 6.7% to $388.5 million.
  • The company posted a GAAP operating loss of $12.5 million and a GAAP net loss of $70.8 million for the quarter.
  • Atlassian expanded its AI solution Rovo to more products and launched new offerings like Government Cloud and Isolated Cloud.

$TFX - Q1 2025 Earnings

  • Teleflex reported Q4 2024 earnings on February 27, 2025: revenue was $795.4 million (up 2.8% year-over-year), adjusted EPS was $3.89 (up 15.1%), and adjusted operating margin rose to 27.6%.
  • The company received FDA 510(k) clearance for expanded use of its QuikClot Control+™ Hemostatic Device.
  • Teleflex will separate into two independent publicly traded companies by mid-2026.
  • The company plans to acquire BIOTRONIK’s Vascular Intervention business for about €760 million, with the deal expected to close by the end of Q3 2025.
  • Upcoming events include the Q1 2025 earnings call on May 1, 2025, and presentations at major healthcare conferences in 2025.

$TRGP - Q1 2025 Earnings

  • Targa Resources reported first quarter 2025 results on May 1, 2025, with record adjusted EBITDA of $1,178.5 million, up 22% from last year.
  • Net income for Q1 2025 was $270.5 million, slightly down from $275.2 million in Q1 2024.
  • The company repurchased $214 million in common shares through April 2025 and raised its annual dividend to $4.00 per share, a 33% increase year over year.
  • Targa expects full year 2025 adjusted EBITDA between $4.65 billion and $4.85 billion, and net growth capital expenditures between $2.6 billion and $2.8 billion.
  • Growth is expected to come from increased activity in the Permian Basin, new processing plants, and expanded LPG export capacity.